Next Article in Journal
Incidence and Outcomes of COVID-19 Vaccine Hypersensitivity Reactions and Success of COVID-19 Vaccine Provocation Tests Post Previous COVID-19 Vaccine Hypersensitivity
Previous Article in Journal
A Modern Approach to the Treatment of Traumatic Brain Injury
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Medicines—Aims and Scope Updates

Meikai University Research Institute of Odontology (M-RIO), 1-1 Keyakidai, Sakado 350-0283, Japan
Medicines 2024, 11(5), 11; https://doi.org/10.3390/medicines11050011
Submission received: 8 May 2024 / Accepted: 8 May 2024 / Published: 14 May 2024
The journal Medicines (ISSN 2305-6320) was launched in 2014. Since then, it has had numerous interesting publications covering all areas of medical disciplines and subspecialties. Following the latest feedback from Scopus, we are updating our scope so it is more in alignment with the papers published in our journal.
We aim to better serve the readers and authors by providing more space for publication in the fields of therapeutic agents and advanced drug studies, but not in those of diet and nutrition, biological and stem-cell therapy, radiation and other nonsurgical therapeutic strategies, palliative care and physical therapy, and multimodal therapy.
Following a thorough review of the published papers and developments in the research fields that we address, we concluded that the subjects that fall within the scope of this journal are perhaps too extensive and could benefit from some fine adjustments. More details are presented in Table 1.
For more information about journal Medicines, please visit the following link: https://www.mdpi.com/journal/medicines/.

Conflicts of Interest

The author declares no conflicts of interest.
Table 1. Changes in the scope of the journal Medicines.
Table 1. Changes in the scope of the journal Medicines.
Aims (New Version)Aims (Old Version)
Medicines (ISSN 2305-6320) is an international, peer-reviewed, and open-access journal aimed at disseminating cutting-edge research in the field of drug discovery and clinical application. This journal welcomes manuscripts covering a wide range of aspects, including the search for target molecules (e.g., receptors), specificity, side effects, hormesis (bimodal actions), emergence of resistance during long-term administration, potentiation by combinational treatment with more than two drugs, and factors that modify its pharmacological actions (such as sex differences, aging, environmental factors, and physiological fluids).

Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Full details must be provided when publishing an experiment so that the results can be reproduced.
Medicines (ISSN 2305-6320) is an international, peer-reviewed, and open access journal aimed at combining all areas of medical disciplines and subspecialties in one platform. It mainly publishes, but is not limited to, original research papers, case reports, reviews, systematic reviews, brief reports, concepts and opinions on all aspects of basic, clinical, and translational research in relation to human health. The journal will accept manuscripts on medical concepts that include evidence-based medicine and/or alternative medicine.

Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Full details must be provided when publishing an experiment so that the results can be reproduced.

There is, in addition, a unique feature of this journal: in studies on complex mixtures of natural products, the characterization of chemicals using analytical methodologies, such as HPLC, MS, LC–MS, HPLC–MS, and NMR, should be included. Pure identification, chemical, and analytical studies are not enough because in vitro or in vivo experiments that investigate their function are needed. It is expected that the cellular and/or molecular mechanisms of natural compounds or characterized extracts will be analyzed in papers.
Scope (New Version)Scope (Old Version)
The following items are suggested (lined up alphabetically):
Clinical application of drugs
Combination effects of more than two drugs
Drug development
Hormesis
Identification of the target molecule of the drug
Modulation factors of drugs (such as aging, sex, microenvironment, and physiological fluids)
Overcoming drug tolerance
Pharmacodynamics
Pharmacokinetics
Specificity and adverse effects of drugs
The main subjects covered include but are not limited to following:
Acpuncture and herbal medicine
Cancer biology and anticancer therapeutics
Cardiology and vascular disease
Endocrinology and metabolic disorders
Gastroenterology & hepatopancreatobiliary medicine
Immunologic and inherited diseases
Infectious diseases
Mental health
Nephrology and urology
Neurology and neurologic diseases
Oral medicine and dentistry
Primary care
Radiology
Obstetrics, gynecology and reproductive medicine
Stem cell investigation and regenerative medicine
Drug exploration and development
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Sakagami, H. Medicines—Aims and Scope Updates. Medicines 2024, 11, 11. https://doi.org/10.3390/medicines11050011

AMA Style

Sakagami H. Medicines—Aims and Scope Updates. Medicines. 2024; 11(5):11. https://doi.org/10.3390/medicines11050011

Chicago/Turabian Style

Sakagami, Hiroshi. 2024. "Medicines—Aims and Scope Updates" Medicines 11, no. 5: 11. https://doi.org/10.3390/medicines11050011

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop